BioCryst Pharmaceuticals Inc (BCRX) valuation · rev $874.8M
BioCryst Pharmaceuticals Inc (BCRX) rev $874.8M.
| Metric | Value |
|---|---|
| Market cap | $1.83B |
| Revenue | $874.8M |
| P/S | 2.1 |
BCRX valuation FAQ
What is BCRX's market cap?
BioCryst Pharmaceuticals Inc (BCRX) market cap is $1.83B on the latest cached fundamentals snapshot.
What is BCRX's latest revenue?
Latest cached BioCryst Pharmaceuticals Inc (BCRX) revenue was $874.8M. Statements: https://lician.com/financials/bcrx
What is BCRX's price-to-sales ratio?
BioCryst Pharmaceuticals Inc (BCRX) price-to-sales (P/S) is 2.1, cached market cap $1.83B divided by revenue $874.8M.
How many BCRX valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for BioCryst Pharmaceuticals Inc (BCRX): Market cap, Revenue, and P/S.
Where is BCRX valuation listed?
Cached valuation multiples for BioCryst Pharmaceuticals Inc (BCRX) are listed at https://lician.com/valuation/bcrx.
Not investment advice. Cached rows, not a live tape.